How Strategic Collaborations Transform Clinical Diagnostics
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
How Strategic Collaborations Transform Clinical Diagnostics
-
Letto da:
-
Di:
A proposito di questo titolo
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss recent industry news and how collaborations are helping drive transformation in clinical diagnostics. Together, they explore:
- Protecting Access to Medicare Act (PAMA) delay (01:09): Dr. Morice shares what the latest delay of PAMA means for laboratories.
- FDA guidance on wearables (02:23): Learn about recent FDA guidance that allows more non‑invasive wearables to be classified as wellness devices.
- Collaboration as a driver of innovation (06:20): Discover why collaboration is critical to advancement in clinical diagnostics.
Note: Information in this post was accurate at the time of its posting.
Resources
- Groundbreaking collaborations
- Mary Jo Williamson offers four steps to maximize collaboration benefits
- Dr. Bill Morice shares how a platform for collaboration transforms diagnostics
- “Answers From the Lab” podcast: “Forging Collaborations That Deliver Better Outcomes”
Ancora nessuna recensione